Webinar Recording: VC 101 for University Entrepreneurs
PCI hosted a webinar with Kirsten Leute and Margalit Haber of Osage University Partners on venture capital and investing for university entrepreneurs in the life science field
Webinar Recording: Penn at the B.PHL
The session, titled Feminine Energy: Female Founders Solving Sustainability Challenges, was a panel format featuring a Penn spinout, Pennovation tenants, and a Penn partner.
Announcing the 2022 Y-Prize: Win $10k For Your Ideas!
For ten years, the Y-Prize Competition has brought Penn students together to unleash their creativity, build their entrepreneurial skills—and win money along the way.
Webinar Recording: New Patenting Strategies for Life Science Inventors
Webinar hosted by the Penn Center for Innovation with Dr. Kathryn Doyle, Partner, Saul Ewing Arnstein & Lehr.
Webinar Recording: Penn Health-Tech
Katherine Reuther, Ph.D., MBA, Executive Director of the Penn Center for Health-Devices and Technology discusses resources to support your medical device idea.
Pennovation Lab welcomes new tenant Interius BioTherapeutics to its innovation ecosystem
Interius BioTherapeutics has signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Recupero Robotics launches
Dr. Johnson and a team of collaborators have launched Recupero Robotics with the help of PCI Ventures.
Webinar Recording: Latest Trends in Life Science Investing
PCI hosted a webinar on Septembe 13, 2021 focused on the latest trends in the venture capital landscape. The speaker was Barbara Schilberg, Managing Director and Chief Executive Officer of BioAdvance.
Penn to play key role in the inaugural NSF Mid-Atlantic I-Corps Hub to advance entrepreneurship and technology commercialization training
PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.
FDA awards Neuralert Technologies Breakthrough Device designation
The Center for Devices and Radiological Health (CDRH) of the FDA has granted the Neuralert Monitor designation as a Breakthrough Device.